Clinical Trials on Folate Receptor-Alpha Positive

Total 428 results

AbbVie

Not yet recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Mirvetuximab Soravtansine-gynx in Adults With Folate Receptor-Alpha Positive, Platinum-Resistant Ovarian Cancer in a Real-World Setting

Folate Receptor-Alpha Positive Platinum-Resistant High-Grade Serous Epithelial Ovarian Cancer | Folate Receptor-Alpha Positive Platinum-Resistant Fallopian Tube Cancer | Folate Receptor-Alpha Positive Platinum-Resistant Primary Peritoneal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione IRCCS... and other collaborators

Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study (PALMARES-2)

Breast Cancer | Breast Neoplasms | Breast Diseases | Breast Neoplasm | Breast Tumors | Breast Carcinoma | Breast Neoplasms, Male | Breast Cancer Stage IV | Hormone Receptor Positive Malignant Neoplasm of Breast | HR-positive Breast Cancer | Hormone Receptor Positive Breast Carcinoma | Hormone Receptor (HR)-Positive... and other conditions

Italy
City of Hope Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Hormone Receptor-Positive Breast Carcinoma | Unresectable Hormone Receptor-Positive Breast Carcinoma | Advanced Hormone Receptor-Positive Breast Carcinoma

United States
National Cancer Institute (NCI)

Terminated

Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive

United States
Massachusetts General Hospital
National Cancer Institute (NCI)

Not yet recruiting

Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocrine Therapy (STRIDE)

Hormone Receptor Positive Breast Cancer

United States

Clinical Trials on Folate Receptor-Alpha Positive

This is a preview